UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
CNBC1 min read
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
AstraZeneca and GSK, the U. K. 's second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC